Xiaoge Sun1, Hao Yang2, Yu Lin1, Jianguo Zhao1, Yinna Bao1, Xiulan Liu1, Zhen Qi1, Shaojun Wang1, Congxiu Huang1, Zhilong Yu1. 1. Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University Tongdao Road, Hohhot 10050, Inner Mongolia, P.R. China. 2. Department of Radiation Oncology, Inner Mongolia Cancer Hospital & The Affiliated People's Hospital of Inner Mongolia Medical University Hohhot, Inner Mongolia, China.
Abstract
BACKGROUND: hOGG1 C8069G polymorphism has been extensively investigated in single studies as well as meta-analyses in terms of the association with colorectal cancer (CRC). But the results remain contradictory. This study was undertaken to comprehensively evaluate the association of the commonly studied hOGG1 C8069G polymorphism and the susceptibility to CRC. METHODS: By searching the electronic databases of PubMed, Embase, and Web of science, 16 available publications consisting of 4,866 cases and 7,363 controls were finally included in our meta-analysis. Stratified analyses by ethnicity and source of control were also carried out to further assess the association between hOGG1 C8069G polymorphism and CRC risk. RESULTS: hOGG1 C8069G polymorphism was not observed to have statistical significance with the susceptibility to CRC (ORCC vs. GG = 0.97, 95% CI = 0.91-1.05; P = 0.995; ORCC + CG vs. GG = 0.98, 95% CI = 0.93-1.04; P = 0.993; ORCC vs. CG + GG = 0.96, 95% CI = 0.90-1.02; P = 0.339; ORallele C vs. allele G = 0.98, 95% CI = 0.94-1.02; P = 0.912; ORCG vs. GG = 0.95, 95% CI = 0.88-1.03; P = 0.526). Similarly, no association was found in the subgroup analysis by ethnicity or the source of control. CONCLUSIONS: The results of our meta-analysis did not demonstrate any evidence for significant association between hOGG1 C8069G polymorphism and CRC risk. Future large-scale studies are expected to be conducted to further confirm our findings.
BACKGROUND:hOGG1C8069G polymorphism has been extensively investigated in single studies as well as meta-analyses in terms of the association with colorectal cancer (CRC). But the results remain contradictory. This study was undertaken to comprehensively evaluate the association of the commonly studied hOGG1C8069G polymorphism and the susceptibility to CRC. METHODS: By searching the electronic databases of PubMed, Embase, and Web of science, 16 available publications consisting of 4,866 cases and 7,363 controls were finally included in our meta-analysis. Stratified analyses by ethnicity and source of control were also carried out to further assess the association between hOGG1C8069G polymorphism and CRC risk. RESULTS:hOGG1C8069G polymorphism was not observed to have statistical significance with the susceptibility to CRC (ORCC vs. GG = 0.97, 95% CI = 0.91-1.05; P = 0.995; ORCC + CG vs. GG = 0.98, 95% CI = 0.93-1.04; P = 0.993; ORCC vs. CG + GG = 0.96, 95% CI = 0.90-1.02; P = 0.339; ORallele C vs. allele G = 0.98, 95% CI = 0.94-1.02; P = 0.912; ORCG vs. GG = 0.95, 95% CI = 0.88-1.03; P = 0.526). Similarly, no association was found in the subgroup analysis by ethnicity or the source of control. CONCLUSIONS: The results of our meta-analysis did not demonstrate any evidence for significant association between hOGG1C8069G polymorphism and CRC risk. Future large-scale studies are expected to be conducted to further confirm our findings.
Authors: Tomasz Sliwinski; Renata Krupa; Maria Wisniewska-Jarosinska; Elzbieta Pawlowska; Justyna Lech; Jan Chojnacki; Janusz Blasiak Journal: Tohoku J Exp Med Date: 2009-07 Impact factor: 1.848
Authors: Steve R Martinez; Shawn E Young; Rebecca E Hoedema; Leland J Foshag; Anton J Bilchik Journal: Ann Surg Oncol Date: 2006-04-12 Impact factor: 5.344
Authors: Karen Curtin; Wade S Samowitz; Roger K Wolff; Cornelia M Ulrich; Bette J Caan; John D Potter; Martha L Slattery Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.254